跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MONTELUKAST OPKO 10 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MONTELUKAST OPKO 10 MG COMPRIMIDOS EFG
Approved
STANDARD
MONTELUKAST OPKO 10 MG COMPRIMIDOS EFG
Opko Health Spain S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 30, 2024
Approval ID
fc0f2e4e72e33df0
Company
Opko Health Spain S.L.U.
Type
Standard
Approval Details
Approval Id
fc0f2e4e72e33df0
Drug Cima Aemps Name
MONTELUKAST OPKO 10 MG COMPRIMIDOS EFG
Register Number
89841
Holder Company Name
Opko Health Spain S.L.U.
Marketing Company Name
Opko Health Spain S.L.U.
Authorization Date
2024-09-30
Dosage Form
COMPRIMIDO
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Opko Health Spain S.L.U.
Active Ingredients
MONTELUKAST SODICO
10,4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 30, 2024
Approval ID
fc0f2e4e72e33df0
Type
Standard
Back to CIMA-AEMPS Approvals